This IHF webinar addresses the complex management of patients with HFrEF and chronic coronary syndrome. 

Through a real-world case study of a 78-year-old patient with worsening dyspnea in the last 3 months (NYHA III) and a history of arterial hypertension and chronic kidney disease, the trans-disciplinary Heart Team debates risk assessment and the crucial choice between CABG and PCI. 

The discussion highlights the value of achieving complete, protected revascularisation (using mechanical circulatory support like Impella) to stabilise high-risk patients, relieve symptoms, and safely facilitate the rapid optimisation of guideline-directed medical therapy.

Watch this iHF Webinar replay if you want:

• To discuss how to select patients with HFrEF and CAD amenable for revascularisation
• To debate on the best revascularisation strategy
• To be updated on the GDMT after the revascularisation